Research programme bids to defuse dementia time bomb

Industry and academia throughout Europe have joined forces in a bid to defuse the dementia time bomb.

The European Prevention of Alzheimer’s Dementia (EPAD) Initiative will test innovative treatments.

It is part of the Innovative Medicines Initiative, a joint undertaking between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA).